Hey-Chi Hsu

764 total citations
16 papers, 624 citations indexed

About

Hey-Chi Hsu is a scholar working on Molecular Biology, Oncology and Cell Biology. According to data from OpenAlex, Hey-Chi Hsu has authored 16 papers receiving a total of 624 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Molecular Biology, 7 papers in Oncology and 4 papers in Cell Biology. Recurrent topics in Hey-Chi Hsu's work include Microtubule and mitosis dynamics (4 papers), Cancer-related Molecular Pathways (4 papers) and Cancer-related gene regulation (3 papers). Hey-Chi Hsu is often cited by papers focused on Microtubule and mitosis dynamics (4 papers), Cancer-related Molecular Pathways (4 papers) and Cancer-related gene regulation (3 papers). Hey-Chi Hsu collaborates with scholars based in Taiwan and France. Hey-Chi Hsu's co-authors include Chao-Lien Liu, Yung‐Ming Jeng, Wen‐Chang Chang, Ju-Ming Wang, Chiung‐Yuan Ko, Meng‐Ru Shen, Chi‐Long Chen, F Y Huang, Po‐Lin Lai and Yu‐Wen Cheng and has published in prestigious journals such as Journal of Biological Chemistry, PLoS ONE and Hepatology.

In The Last Decade

Hey-Chi Hsu

16 papers receiving 609 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Hey-Chi Hsu Taiwan	14	297	264	110	108	97	16	624
Vito Gomes Italy	8	313 1.1×	218 0.8×	109 1.0×	145 1.3×	111 1.1×	22	656
Deyun Feng China	16	376 1.3×	216 0.8×	200 1.8×	47 0.4×	85 0.9×	46	702
Kenichi Taguchi Japan	16	235 0.8×	214 0.8×	105 1.0×	211 2.0×	134 1.4×	19	688
Kostas Evangelou Greece	11	303 1.0×	144 0.5×	56 0.5×	71 0.7×	102 1.1×	15	533
Shanhong Tang China	14	516 1.7×	509 1.9×	177 1.6×	125 1.2×	141 1.5×	30	1.1k
Iwao Yabuuchi Japan	9	276 0.9×	252 1.0×	95 0.9×	65 0.6×	183 1.9×	17	645
Liliana Terrin Italy	13	322 1.1×	202 0.8×	95 0.9×	42 0.4×	102 1.1×	21	707
Motoko Seto Japan	12	420 1.4×	223 0.8×	86 0.8×	96 0.9×	54 0.6×	17	603
Y. Miyauchi Japan	11	192 0.6×	184 0.7×	62 0.6×	120 1.1×	108 1.1×	17	515
Toshiki Komeda Japan	14	425 1.4×	367 1.4×	194 1.8×	111 1.0×	175 1.8×	27	864

Countries citing papers authored by Hey-Chi Hsu

Since Specialization

Citations

This map shows the geographic impact of Hey-Chi Hsu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hey-Chi Hsu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hey-Chi Hsu more than expected).

Fields of papers citing papers by Hey-Chi Hsu

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hey-Chi Hsu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hey-Chi Hsu. The network helps show where Hey-Chi Hsu may publish in the future.

Co-authorship network of co-authors of Hey-Chi Hsu

This figure shows the co-authorship network connecting the top 25 collaborators of Hey-Chi Hsu. A scholar is included among the top collaborators of Hey-Chi Hsu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hey-Chi Hsu. Hey-Chi Hsu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

16 of 16 papers shown

Shao, Yu‐Yun, Yung‐Ming Jeng, Yao‐Ming Wu, et al.. (2021). Eg5 as a Prognostic Biomarker and Potential Therapeutic Target for Hepatocellular Carcinoma. Cells. 10(7). 1698–1698. 14 indexed citations

Cheng, Wei, et al.. (2017). Glypican-3 induces oncogenicity by preventing IGF-1R degradation, a process that can be blocked by Grb10. Oncotarget. 8(46). 80429–80442. 13 indexed citations

Chen, Chi‐Long, Hung Hung, Pei‐Ming Yang, et al.. (2013). Upregulation of Endocan by Epstein-Barr Virus Latent Membrane Protein 1 and Its Clinical Significance in Nasopharyngeal Carcinoma. PLoS ONE. 8(12). e82254–e82254. 21 indexed citations

Lin, Zhong-Zhe, Hey-Chi Hsu, Chih‐Hung Hsu, et al.. (2008). The Aurora kinase inhibitor VE-465 has anticancer effects in pre-clinical studies of human hepatocellular carcinoma. Journal of Hepatology. 50(3). 518–527. 43 indexed citations

Ko, Chiung‐Yuan, Hey-Chi Hsu, Meng‐Ru Shen, Wen‐Chang Chang, & Ju-Ming Wang. (2008). Epigenetic Silencing of CCAAT/Enhancer-binding Protein δ Activity by YY1/Polycomb Group/DNA Methyltransferase Complex. Journal of Biological Chemistry. 283(45). 30919–30932. 75 indexed citations

Liu, Chao-Lien, et al.. (2006). Role of L2DTL, Cell Cycle-Regulated Nuclear and Centrosome Protein, in Aggressive HepatocellularCarcinoma. Cell Cycle. 5(22). 2676–2687. 70 indexed citations

Cheng, Yu‐Wen, et al.. (2006). Physiological and Functional Interactions between Tcf4 and Daxx in Colon Cancer Cells. Journal of Biological Chemistry. 281(22). 15405–15411. 34 indexed citations

Yeh, Shiou-Hwei, Ming‐Wei Lin, Shih-Feng Tsai, et al.. (2004). Allelic loss of chromosome 4q21 ≈ 23 associates with hepatitis B Virus—related hepatocarcinogenesis and elevated alpha-fetoprotein. Hepatology. 40(4). 847–854. 20 indexed citations

Huang, Shiu‐Feng, et al.. (2003). Tetrasomy 6 and 6q14 deletion are associated with better survival in hepatocellular carcinomas. Cancer Genetics and Cytogenetics. 144(1). 23–30. 4 indexed citations

10.

Jeng, Yung‐Ming, et al.. (2002). Down-Regulation of Annexin A10 in Hepatocellular Carcinoma Is Associated with Vascular Invasion, Early Recurrence, and Poor Prognosis in Synergy with p53 Mutation. American Journal Of Pathology. 160(5). 1831–1837. 78 indexed citations

11.

Hsu, Hey-Chi, et al.. (1996). Expression of epstein-barr virus in carcinomas of major salivary glands: A strong association with lymphoepithelioma-like carcinoma. Human Pathology. 27(3). 258–262. 94 indexed citations

12.

Hsu, Hey-Chi, A‐Min Huang, Po‐Lin Lai, et al.. (1994). Genetic alterations at the splice junction of p53 gene in human hepatocellular carcinoma. Hepatology. 19(1). 122–128. 29 indexed citations

13.

Chen, Chi‐Long, et al.. (1993). Detection of Epstein-Barr Virus Genome in Nasopharyngeal Carcinoma by In situ DNA Hybridization. Intervirology. 36(2). 91–98. 56 indexed citations

14.

Hsu, Hey-Chi, et al.. (1989). Membranous nephropathy in 52 hepatitis B surface antigen (HBsAg) carrier children in Taiwan. Kidney International. 36(6). 1103–1107. 34 indexed citations

15.

Wu, Tsung‐Teh, Hey-Chi Hsu, Ding‐Shinn Chen, et al.. (1987). Clearance of hepatitis B surface antigen (HBsAg) after surgical resection of hepatocellular carcinoma. Journal of Hepatology. 4(1). 45–51. 28 indexed citations

16.

Lin, Ching-Yuang, et al.. (1986). Serial immunologic and histopathologic studies in the treatment of necrotizing fasciitis with combined immunodeficiency by a bovine thymic extract (Thymostimulin). Journal of Pediatric Surgery. 21(11). 1000–1004. 11 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact